Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis
Objective. To investigate the mechanism of Connexin 37 (Cx37) and Kv1.3 pathways in atherosclerosis (AS). Methods. ApoE-/- mice were given a high-fat diet to establish atherosclerosis (AS) model, and macrophages in mice were isolated and extracted to transfect Cx37 vectors with silencing or overexpr...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2022/2689918 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549723082326016 |
|---|---|
| author | Minqi Liao Lihua Chen Jiongbin Lu Guangzhu Liang Yongzhao Yao Shumin Ouyang Yanhua Yang Zhengwei Jian Suxia Guo |
| author_facet | Minqi Liao Lihua Chen Jiongbin Lu Guangzhu Liang Yongzhao Yao Shumin Ouyang Yanhua Yang Zhengwei Jian Suxia Guo |
| author_sort | Minqi Liao |
| collection | DOAJ |
| description | Objective. To investigate the mechanism of Connexin 37 (Cx37) and Kv1.3 pathways in atherosclerosis (AS). Methods. ApoE-/- mice were given a high-fat diet to establish atherosclerosis (AS) model, and macrophages in mice were isolated and extracted to transfect Cx37 vectors with silencing or overexpressing, and Kv1.3 pathway blockers were used to inhibit the pathway activity. The indexes of body weight, blood glucose, and blood lipid of mice were collected. The protein and mRNA expression levels of Cx37 and Kv1.3 were detected by reverse transcription-PCR (RT-PCR), Western blot, and immunofluorescence technique. Oil red O staining was used to observe plaque area. Masson staining was used to detect collagen content. The concentrations of chemokine CCL7 were quantified using the ELISA kits. CCK8 was used to detect cell proliferation. Results. Cx37 and Kv1.3 were highly expressed in macrophages of AS mice, and the expression of Kv1.3 and CCL7 decreased after Cx37 was silenced, and the proliferation of macrophages was also decreased. Wild-type mice and AS model mice were treated with Cx37 overexpression vectors and Kv1.3 pathway blocking, and it was found that Cx37 overexpression could improve the blood lipid and blood glucose levels and increase the area of AS in AS mice. However, blocking the activity of Kv1.3 pathway can reduce the levels of blood lipid and blood glucose, increase the body weight of mice, and reduce the area of AS mice. Blocking the activity of Kv1.3 pathway can slow down the plaque development of AS mice and make its indexes close to wild-type mice. And the use of Kv1.3 pathway blockers on the basis of overexpression of Cx37 indicated that inhibition of Kv1.3 pathway activity did not affect the expression of Cx37, but could inhibit the collagen content in the plaque area of AS mice, inhibit the expression of chemokine CCL7, and reverse the effect of Cx37 overexpression. Conclusion. Cx37 can improve the activity of macrophages by regulating the expression of chemokines and the activity of Kv1.3 pathway in AS mice, and enrich macrophages in inflammatory tissues and expand the area of plaque formation. |
| format | Article |
| id | doaj-art-74699d415bcf4540b22fb1ecfc05d714 |
| institution | Kabale University |
| issn | 1466-1861 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-74699d415bcf4540b22fb1ecfc05d7142025-02-03T06:08:45ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/2689918Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of AtherosclerosisMinqi Liao0Lihua Chen1Jiongbin Lu2Guangzhu Liang3Yongzhao Yao4Shumin Ouyang5Yanhua Yang6Zhengwei Jian7Suxia Guo8Department of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyObjective. To investigate the mechanism of Connexin 37 (Cx37) and Kv1.3 pathways in atherosclerosis (AS). Methods. ApoE-/- mice were given a high-fat diet to establish atherosclerosis (AS) model, and macrophages in mice were isolated and extracted to transfect Cx37 vectors with silencing or overexpressing, and Kv1.3 pathway blockers were used to inhibit the pathway activity. The indexes of body weight, blood glucose, and blood lipid of mice were collected. The protein and mRNA expression levels of Cx37 and Kv1.3 were detected by reverse transcription-PCR (RT-PCR), Western blot, and immunofluorescence technique. Oil red O staining was used to observe plaque area. Masson staining was used to detect collagen content. The concentrations of chemokine CCL7 were quantified using the ELISA kits. CCK8 was used to detect cell proliferation. Results. Cx37 and Kv1.3 were highly expressed in macrophages of AS mice, and the expression of Kv1.3 and CCL7 decreased after Cx37 was silenced, and the proliferation of macrophages was also decreased. Wild-type mice and AS model mice were treated with Cx37 overexpression vectors and Kv1.3 pathway blocking, and it was found that Cx37 overexpression could improve the blood lipid and blood glucose levels and increase the area of AS in AS mice. However, blocking the activity of Kv1.3 pathway can reduce the levels of blood lipid and blood glucose, increase the body weight of mice, and reduce the area of AS mice. Blocking the activity of Kv1.3 pathway can slow down the plaque development of AS mice and make its indexes close to wild-type mice. And the use of Kv1.3 pathway blockers on the basis of overexpression of Cx37 indicated that inhibition of Kv1.3 pathway activity did not affect the expression of Cx37, but could inhibit the collagen content in the plaque area of AS mice, inhibit the expression of chemokine CCL7, and reverse the effect of Cx37 overexpression. Conclusion. Cx37 can improve the activity of macrophages by regulating the expression of chemokines and the activity of Kv1.3 pathway in AS mice, and enrich macrophages in inflammatory tissues and expand the area of plaque formation.http://dx.doi.org/10.1155/2022/2689918 |
| spellingShingle | Minqi Liao Lihua Chen Jiongbin Lu Guangzhu Liang Yongzhao Yao Shumin Ouyang Yanhua Yang Zhengwei Jian Suxia Guo Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis Mediators of Inflammation |
| title | Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis |
| title_full | Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis |
| title_fullStr | Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis |
| title_full_unstemmed | Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis |
| title_short | Connexin 37 Regulates the Kv1.3 Pathway and Promotes the Development of Atherosclerosis |
| title_sort | connexin 37 regulates the kv1 3 pathway and promotes the development of atherosclerosis |
| url | http://dx.doi.org/10.1155/2022/2689918 |
| work_keys_str_mv | AT minqiliao connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT lihuachen connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT jiongbinlu connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT guangzhuliang connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT yongzhaoyao connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT shuminouyang connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT yanhuayang connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT zhengweijian connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis AT suxiaguo connexin37regulatesthekv13pathwayandpromotesthedevelopmentofatherosclerosis |